Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Features

Go Red for Women: Nearly 20 Years of Much Progress, Some Setbacks

Caitlin E. Cox

February 03, 2023

News Features

As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise?

Todd Neale

January 13, 2022

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

Todd Neale

December 09, 2021

News Features

$45 Million OHSU Lawsuit Hits a Nerve for #CardiologyToo

Caitlin E. Cox

March 05, 2021

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Features

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

Shelley Wood

April 02, 2020

News Features

TCTMD Looks Back on 5 Years of Its Kahn Journalism Fellowship

L.A. McKeown

December 26, 2019

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

L.A. McKeown

February 26, 2018

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Denervación Renal 2.0: Marcando el Camino de la Recuperación Tras el Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

Advertisement

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Go Red for Women: Nearly 20 Years of Much Progress, Some Setbacks

As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise?

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

$45 Million OHSU Lawsuit Hits a Nerve for #CardiologyToo

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

Cardiology After COVID-19: Physicians Predict Lasting Change

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

TCTMD Looks Back on 5 Years of Its Kahn Journalism Fellowship

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Denervación Renal 2.0: Marcando el Camino de la Recuperación Tras el Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content